ARWR three-lens brief
Evidence-based stock research on ARWR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $110.00 — 33% above current (12 analysts). · Currently unprofitable on a trailing basis — no P/E multiple available.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $110.00 — 33% above current (12 analysts).
- Negative free cash flow last quarterly (-$48.63M).
- Debt-to-equity of 296% — balance-sheet-heavy.
ARWR closed at $82.76 (+0.16%) as of 2026-09-11. Market cap: $11.66B. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $110.00 — 33% above current (12 analysts).. Concerns: currently unprofitable on a trailing basis — no P/E multiple available.; negative free cash flow last quarterly (-$48.63M).. Last quarter: Revenue $75.25M, net income -$194.28M, free cash flow -$48.63M.
Why three lenses on ARWR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARWRacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ARWR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARWR brief"></iframe>